SR

Sonalben Rajubhai Dhameliya

Active Director Designated Partner DIN 11656033
DIN 11656033 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sonalben Rajubhai Dhameliya

Data last updated:

Sonalben Rajubhai Dhameliya is a Designated Partner at Zyconix Biologics Llp (since 2026).

DIN 11656033
Primary Designation Designated Partner
First Appointment 09 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Apr 20262026Active

Board colleagues of Sonalben Rajubhai Dhameliya

NameDINCompanyDesignation
Jalpaben Vipulkumar Patel11656032Zyconix Biologics LlpDesignated Partner
Sarojben Chandulal Pathak11656034Zyconix Biologics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Zyconix Biologics Llp
Premium access

Shareholding and investment profile for Sonalben Rajubhai Dhameliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonalben Rajubhai Dhameliya

Sonalben Rajubhai Dhameliya currently holds 1 directorship: Zyconix Biologics Llp (Designated Partner, since 09 Apr 2026).

Sonalben Rajubhai Dhameliya was first appointed on 09 Apr 2026 as Designated Partner at Zyconix Biologics Llp.

The current boards of Sonalben Rajubhai Dhameliya's companies include Jalpaben Vipulkumar Patel (Zyconix Biologics Llp), Sarojben Chandulal Pathak (Zyconix Biologics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available